Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Kälin

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Praxis|May 26, 2016
[Testicular Cancer: Diagnostics, Therapy and Follow Up]Martin Kälin, Laetitia Mauti, Miklos Pless
Praxis|August 16, 2016
[Not Available]Jan Brachlow, Martin Kälin, Marco Randazzo, et al.
European Urology|July 12, 2011
Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteomeMartin Kälin, Igor Cima, Ralph Schiess, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Praxis|May 26, 2016
[Testicular Cancer: Diagnostics, Therapy and Follow Up]Martin Kälin, Laetitia Mauti, Miklos Pless
Praxis|August 16, 2016
[Not Available]Jan Brachlow, Martin Kälin, Marco Randazzo, et al.
European Urology|July 12, 2011
Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteomeMartin Kälin, Igor Cima, Ralph Schiess, et al.
Pageof 1